A genomic test panel was developed at Duke University's Institute for Genome Sciences & Policy. The panel of tests can be utilized to analyze the "unique molecular traits of a cancerous tumor" and determine "which chemotherapy will most aggressively attack that patient's cancer":
"In experiments reported in the November 2006 issue of the journal Nature Medicine, the researchers applied the genomic tests to cells derived from tumors of cancer patients. They found that the tests were 80 percent accurate in predicting which drugs would be most effective in killing the tumor.
The Duke team plans to begin a clinical trial of the genomic tests in breast cancer patients next year."
How cool is that!
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment